| __timestamp | Amphastar Pharmaceuticals, Inc. | Axsome Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 4279200 |
| Thursday, January 1, 2015 | 37065000 | 6776987 |
| Friday, January 1, 2016 | 41199000 | 21199860 |
| Sunday, January 1, 2017 | 43415000 | 19957616 |
| Monday, January 1, 2018 | 57564000 | 23495055 |
| Tuesday, January 1, 2019 | 68853000 | 53647067 |
| Wednesday, January 1, 2020 | 67229000 | 70244579 |
| Friday, January 1, 2021 | 60932000 | 58060725 |
| Saturday, January 1, 2022 | 74771000 | 57947447 |
| Sunday, January 1, 2023 | 73741000 | 97944000 |
| Monday, January 1, 2024 | 187077000 |
Unleashing the power of data
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Axsome Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
Axsome Therapeutics has shown a remarkable increase in its R&D budget, growing by over 2,000% from 2014 to 2023. This surge reflects the company's aggressive pursuit of new therapies, culminating in a peak investment in 2023.
In contrast, Amphastar Pharmaceuticals has maintained a steady R&D expenditure, with a 160% increase over the same period. This consistent approach underscores their focus on incremental innovation and product enhancement.
As these companies continue to evolve, their R&D strategies will play a crucial role in shaping the future of healthcare.
Research and Development Investment: Pfizer Inc. vs Axsome Therapeutics, Inc.
Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Biogen Inc. vs Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Axsome Therapeutics, Inc.
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Axsome Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs MorphoSys AG
Analyzing R&D Budgets: Axsome Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
R&D Insights: How Axsome Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds
Amphastar Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending